Loading...

Rohit Vashisht, PhD

Title(s)Professional Research, Computational Health Scienc
SchoolSchool of Medicine
EmailRohit.Vashisht@ucsf.edu
ORCID ORCID Icon0000-0002-2938-7259 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Warsinske H, Vashisht R, Khatri P. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures. PLoS Med. 2019 04; 16(4):e1002786. PMID: 31013272.
      View in: PubMed
    2. Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, Li L, Dudley JT, Johnson KW, Shervey MM, Xu H, Wu Y, Natrajan K, Hripcsak G, Jin P, Van Zandt M, Reckard A, Reich CG, Weaver J, Schuemie MJ, Ryan PB, Callahan A, Shah NH. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative. JAMA Netw Open. 2018 08 03; 1(4):e181755. PMID: 30646124.
      View in: PubMed
    3. Bhatt R, Chopra K, Vashisht R. Impact of integrated psycho-socio-economic support on treatment outcome in drug resistant tuberculosis - A retrospective cohort study. Indian J Tuberc. 2019 Jan; 66(1):105-110. PMID: 30797265.
      View in: PubMed
    4. Vashisht R, Jung K, Shah N. Learning Effective Treatment Pathways for Type-2 Diabetes from a clinical data warehouse. AMIA Annu Symp Proc. 2016; 2016:2036-2042. PMID: 28269963.
      View in: PubMed
    5. Vashisht R, Brahmachari SK. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 2015 Mar 07; 13:83. PMID: 25880846.
      View in: PubMed
    6. Vashisht R, Bhat AG, Kushwaha S, Bhardwaj A. Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets. J Transl Med. 2014 Oct 11; 12:263. PMID: 25304862.
      View in: PubMed
    7. Vashisht R, Bhardwaj A. Social networks to biological networks: systems biology of Mycobacterium tuberculosis. Mol Biosyst. 2013 Jul; 9(7):1584-93. PMID: 23629487.
      View in: PubMed
    8. Vashisht R, Mondal AK, Jain A, Shah A, Vishnoi P, Priyadarshini P, Bhattacharyya K, Rohira H, Bhat AG, Passi A, Mukherjee K, Choudhary KS, Kumar V, Arora A, Munusamy P, Subramanian A, Venkatachalam A, Gayathri S, Raj S, Chitra V, Verma K, Zaheer S, Balaganesh J, Gurusamy M, Razeeth M, Raja I, Thandapani M, Mevada V, Soni R, Rana S, Ramanna GM, Raghavan S, Subramanya SN, Kholia T, Patel R, Bhavnani V, Chiranjeevi L, Sengupta S, Singh PK, Atray N, Gandhi S, Avasthi TS, Nisthar S, Anurag M, Sharma P, Hasija Y, Dash D, Sharma A, Scaria V, Thomas Z, Chandra N, Brahmachari SK, Bhardwaj A. Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis. PLoS One. 2012; 7(7):e39808. PMID: 22808064.
      View in: PubMed
    9. Bhat AG, Vashisht R, Chandra N. Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid. Syst Synth Biol. 2010 Dec; 4(4):299-309. PMID: 22132057.
      View in: PubMed
    10. Padiadpu J, Vashisht R, Chandra N. Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol. 2010 Dec; 4(4):311-22. PMID: 22132058.
      View in: PubMed
    11. Raman K, Vashisht R, Chandra N. Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Mol Biosyst. 2009 Dec; 5(12):1740-51. PMID: 19593474.
      View in: PubMed